Skip to main content
Premium Trial:

Request an Annual Quote

Fluorotechnics Q2 Revenues Drop to $129K

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Fluorotechnics last week reported that second-quarter revenues from customers had dropped to A$119,189 ($129,151), down from A$1.9 million ($2.1 million) a year ago.

For the quarter ended June 30, R&D expenses were sliced to A$9,425 from $264,231 a yaer ago, while SG&A spending dropped to A$1,169 from A$354,777.

Net operating cash flows came in at a loss of A$87,601, down from a loss of A$1.6 million in the second quarter of 2010.

As of June 30, the Australian fluorescence and protein detection technologies firm had A$189,278 in cash.

The company is in the midst of a restructuring effort that includes the scaling back of its operations and sale of certain of its assets. Ian Gilmour, Fluorotechnic's secretary, said in a note that the company is continuing the process "for the orderly sale of the remaining operations and assets."

He added that the company "is continuing to review new investment opportunities."

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.